BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1916001)

  • 1. The type 1 diabetes and HLA-DR in Turkey.
    Ozsahin H; Haktan M; Ozbakir F; Aydin A; Yazici H
    Diabete Metab; 1991; 17(4):421-3. PubMed ID: 1916001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA A, B, and DR antigens and complotype in Tunisian patients with diabetes mellitus.
    Ayed K; Bardi R; Gorgi Y; Jenhani F; Chammakhi S; Boukhris R
    Dis Markers; 1989; 7(1):43-7. PubMed ID: 2714046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. DiMe Study Group. Childhood Diabetes in Finland.
    Langholz B; Tuomilehto-Wolf E; Thomas D; Pitkäniemi J; Tuomilehto J
    Genet Epidemiol; 1995; 12(5):441-53. PubMed ID: 8557177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of HLA antigens with diabetes mellitus in an Iraqi population.
    Jabbar AA; Mezaal TJ; Dawood FH
    Dis Markers; 1989; 7(2):79-85. PubMed ID: 2731409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predisposition and IDDM in Greece.
    Karayanni C; Anastasiadou V; Spyropoulou M; Delis D; Khalil I; Lepage V; Papanicolaoy M; Varla M; Stavropoulou A; Bartsocas CS
    Genet Couns; 1993; 4(3):181-6. PubMed ID: 8267924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA; Keller U; Neri TM; Matter L; Staffelbach O; Berger W
    Schweiz Med Wochenschr; 1985 Jan; 115(2):48-54. PubMed ID: 3881821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA and insulin gene associations with IDDM.
    Thomson G; Robinson WP; Kuhner MK; Joe S; Klitz W
    Genet Epidemiol; 1989; 6(1):155-60. PubMed ID: 2567257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective.
    Maclaren N; Riley W; Skordis N; Atkinson M; Spillar R; Silverstein J; Klein R; Vadheim C; Rotter J
    Autoimmunity; 1988; 1(3):197-205. PubMed ID: 2979618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of age and gender on HLA-DR in Chinese child-onset type 1 diabetes mellitus patients.
    Chen BH; Chiang W; Yen JH; Chao MG
    Kaohsiung J Med Sci; 2000 Aug; 16(8):393-9. PubMed ID: 11221543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential transmission of diabetic alleles within the HLA gene complex.
    Vadheim CM; Rotter JI; Maclaren NK; Riley WJ; Anderson CE
    N Engl J Med; 1986 Nov; 315(21):1314-8. PubMed ID: 3490623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The susceptible alleles on HLA-DRB 1 of type I diabetes in children in Harbin].
    Zhang H; Wang B; Zhao X; Sun J; Liang Z; Zhang D; Yang Z; Sun Y; Shen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):267-9. PubMed ID: 11860796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune thyroid phenomena are not evidence for human lymphocyte antigen-genetic heterogeneity in insulin-dependent diabetes.
    Allen DB; MacDonald MJ; Gottschall JL; Hunter JB
    Am J Med Genet; 1989 Jul; 33(3):405-8. PubMed ID: 2801776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen.
    Aribi M; Moulessehoul S; Benabadji AB; Kendoucitani M
    BMC Genet; 2004 Aug; 5():24. PubMed ID: 15331022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No association between rheumatoid arthritis and insulin dependent diabetes mellitus: an epidemiologic and immunogenetic study.
    Hakala M; Ilonen J; Reijonen H; Knip M; Koivisto O; Isomäki H
    J Rheumatol; 1992 Jun; 19(6):856-8. PubMed ID: 1357169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
    Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR alleles are associated with IDDM, but not with impaired neutrophil chemotaxis in IDDM.
    Gustke CJ; Stein SH; Hart TC; Hoffman WH; Hanes PJ; Russell CM; Schuster GS; Watson SC
    J Dent Res; 1998 Jul; 77(7):1497-503. PubMed ID: 9663434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of cis and trans interactions between extended HLA-haplotypes in insulin-dependent diabetes.
    Deschamps I; Marcelli-Barge A; Lallemand N; Poirier JC; Bochu V; Prévost P; Busson A; Massét M; Lestradet H; Hors J
    Tissue Antigens; 1988 May; 31(5):259-69. PubMed ID: 3400091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leucocyte antigen and insulin dependent diabetes mellitus.
    Gupta MM; Raghunath D; Kher SK; Radhakrishnan AP
    J Assoc Physicians India; 1991 Jul; 39(7):540-3. PubMed ID: 1724775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA DR antigens in adult-onset and juvenile-onset Japanese insulin-dependent diabetic patients.
    Matsuda A; Kuzuya T; Iwamoto Y; Yoshioka N; Awata T; Kumakura S; Ohwada N
    Diabetes Res Clin Pract; 1988 Jul; 5(2):107-12. PubMed ID: 3416708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.